{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:29:59Z","timestamp":1793672999124,"version":"4.5.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00393-025-01626-y","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T01:22:36Z","timestamp":1739841756000},"page":"140-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Juvenile idiopathische Arthritis\u00a0\u2013 Diagnose und Management","Juvenile idiopathic arthritis\u2014Diagnosis and management"],"prefix":"10.1007","volume":"84","author":[{"given":"Normi","family":"Br\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad Thomas","family":"Oommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"issue":"1","key":"1626_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12969-022-00755-x","volume":"20","author":"G Horneff","year":"2022","unstructured":"Horneff\u00a0G, Borchert\u00a0J, Heinrich\u00a0R et\u00a0al (2022) Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a\u00a0retrospective observational cohort health claims database study. Pediatr Rheumatol Online\u00a0J 20(1):100. https:\/\/doi.org\/10.1186\/s12969-022-00755-x","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"1626_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty\u00a0RE, Southwood\u00a0TR, Manners\u00a0P et\u00a0al (2004) International league of associations for rheumatology. J\u00a0Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"2","key":"1626_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3899\/jrheum.180168","volume":"46","author":"A Martini","year":"2019","unstructured":"Martini\u00a0A, Ravelli\u00a0A, Avcin\u00a0T et\u00a0al (2019) Pediatric Rheumatology International Trials Organization (PRINTO). Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. J\u00a0Rheumatol 46(2):190\u2013197. https:\/\/doi.org\/10.3899\/jrheum.180168","journal-title":"J Rheumatol"},{"issue":"6","key":"1626_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/acr.25296","volume":"76","author":"SJW Shoop-Worrall","year":"2024","unstructured":"Shoop-Worrall\u00a0SJW, Macintyre\u00a0VG, Ciurtin\u00a0C et\u00a0al (2024) Overlap of International League of Associations for Rheumatology and Preliminary Pediatric Rheumatology International Trials Organization Classification Criteria for Nonsystemic Juvenile Idiopathic Arthritis in an Established UK Multicentre Inception Cohort. Arthritis Care Res 76(6):831\u2013840. https:\/\/doi.org\/10.1002\/acr.25296 (Childhood Arthritis Prospective Study (CAPS) Principal Investigators)","journal-title":"Arthritis Care Res"},{"issue":"12","key":"1626_CR5","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/ard-2024-225851","volume":"83","author":"B Fautrel","year":"2024","unstructured":"Fautrel\u00a0B, Mitrovic\u00a0S, De Matteis\u00a0A et\u00a0al (2024) EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease. Ann Rheum Dis 83(12):1614\u20131627. https:\/\/doi.org\/10.1136\/ard-2024-225851","journal-title":"Ann Rheum Dis"},{"key":"1626_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/rheumatology\/kem053","volume":"46","author":"A Heiligenhaus","year":"2007","unstructured":"Heiligenhaus\u00a0A, Niewerth\u00a0M, Ganser\u00a0G et\u00a0al (2007) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a\u00a0population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 46:1015\u20131019","journal-title":"Rheumatology"},{"issue":"1","key":"1626_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semarthrit.2018.11.004","volume":"49","author":"A Heiligenhaus","year":"2019","unstructured":"Heiligenhaus\u00a0A, Minden\u00a0K, Tappeiner\u00a0C et\u00a0al (2019) Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum 49(1):43\u201355","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1626_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/art.40443","volume":"70","author":"A Hinks","year":"2018","unstructured":"Hinks\u00a0A, Marion\u00a0MC, Cobb\u00a0J et\u00a0al (2018) Brief report: the genetic profile of rheumatoid factor-positive Polyarticular juvenile idiopathic arthritis resembles that of adult rheumatoid arthritis. Arthritis Rheumatol 70(6):957\u2013962. https:\/\/doi.org\/10.1002\/art.40443","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1626_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ng.2614","volume":"45","author":"A Hinks","year":"2013","unstructured":"Hinks\u00a0A, Cobb\u00a0J, Marion\u00a0MC et\u00a0al (2013) Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 45(6):664\u2013669. https:\/\/doi.org\/10.1038\/ng.2614","journal-title":"Nat Genet"},{"issue":"8","key":"1626_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrrheum.2010.103","volume":"6","author":"RA Colbert","year":"2010","unstructured":"Colbert\u00a0RA (2010) Classification of juvenile spondyloarthritis: Enthesitis-related arthritis and beyond. Nat Rev Rheumatol 6(8):477\u2013485. https:\/\/doi.org\/10.1038\/nrrheum.2010.103","journal-title":"Nat Rev Rheumatol"},{"key":"1626_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/2475530318799072","volume":"4","author":"TG Brandon","year":"2018","unstructured":"Brandon\u00a0TG, Manos\u00a0CK, Xiao\u00a0R et\u00a0al (2018) J\u00a0Psoriasis Psoriatic Arthritis 4:131\u2013136","journal-title":"J Psoriasis Psoriatic Arthritis"},{"issue":"11","key":"1626_CR12","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/art.41073","volume":"71","author":"GS Schulert","year":"2019","unstructured":"Schulert\u00a0GS, Yasin\u00a0S, Carey\u00a0B et\u00a0al (2019) Systemic juvenile idiopathic arthritis-associated lung disease: characterization and risk factors. Arthritis Rheumatol 71(11):1943\u20131954. https:\/\/doi.org\/10.1002\/art.41073","journal-title":"Arthritis Rheumatol"},{"key":"1626_CR13","first-page":"237","volume":"11","author":"DC Fair","year":"2019","unstructured":"Fair\u00a0DC, Rodriguez\u00a0M, Knight\u00a0AM et\u00a0al (2019) Depression and anxiety in patients with juvenile idiopathic arthritis: current insights and impact on quality of life, A\u00a0systematic review. Open Access Rheumatol Res Rev 11:237\u2013252","journal-title":"Open Access Rheumatol Res Rev"},{"key":"1626_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13075-024-03312-x","volume":"26","author":"F Milatz","year":"2024","unstructured":"Milatz\u00a0F, Klotsche\u00a0J, Niewerth\u00a0M et\u00a0al (2024) Anxiety and depression symptoms in adolescents and young adults with juvenile idiopathic arthritis: results of an outpatient screening. Arthritis Res Ther 26:82","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1626_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1055\/a-1161-5382","volume":"40","author":"PT Oommen","year":"2020","unstructured":"Oommen P, Hinze C, Holzinger D et\u00a0al (2020) Therapie der juvenilen idiopathischen Arthritis. Arthritis Rheum 40(4):260\u2013269. https:\/\/doi.org\/10.1055\/a-1161-5382","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1626_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12969-018-0224-2","volume":"16","author":"CH Hinze","year":"2018","unstructured":"Hinze\u00a0CH, Holzinger\u00a0D, Lainka\u00a0E et\u00a0al (2018) Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany. Pediatr Rheumatol Online\u00a0J 16(1):7","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"1626_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12969-017-0206-9","volume":"15","author":"G Horneff","year":"2017","unstructured":"Horneff\u00a0G, Klein\u00a0A, Ganser\u00a0G et\u00a0al (2017) Protocols on classification, monitoring and therapy in children\u2019s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online\u00a0J 15(1):78","journal-title":"Pediatr Rheumatol Online J"},{"issue":"02","key":"1626_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1055\/s-0038-1649293","volume":"38","author":"A Hospach","year":"2018","unstructured":"Hospach\u00a0A, Trauzeddel\u00a0R, Windschall\u00a0D et\u00a0al (2018) Protokolle zur Klassifikation, \u00dcberwachung und Therapie in der Kinderrheumatologie (PRO-KIND): Enthesitis-assoziierte Arthritis. Ergebnisse der Arbeitsgruppe Enthesitis-assoziierte Arthritis in der GKJR-Kommission PRO-KIND. Arthritis Rheuma 38(02):132\u2013140","journal-title":"Arthritis Rheuma"},{"issue":"1","key":"1626_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12969-021-00514-4","volume":"19","author":"T Welzel","year":"2021","unstructured":"Welzel\u00a0T, Winskill\u00a0C, Zhang\u00a0N et\u00a0al (2021) Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology\u2014what we know and what we do not know from randomized controlled trials. Pediatr Rheumatol Online\u00a0J 19(1):46","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"1626_CR20","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1093\/rheumatology\/keaa118","volume":"59","author":"A Chhabra","year":"2020","unstructured":"Chhabra\u00a0A, Robinson\u00a0C, Houghton\u00a0K et\u00a0al (2020) Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a\u00a0two-centre experience. Rheumatology 59(12):3727\u20133730","journal-title":"Rheumatology"},{"key":"1626_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s12098-021-03854-x","volume":"88","author":"R Yadav","year":"2021","unstructured":"Yadav\u00a0R, Bolia\u00a0R, Bhat\u00a0NK (2021) Inappropriate prescribing of proton pump inhibitors in children: insights from a\u00a0survey. Indian J Pediatr 88:1055","journal-title":"Indian J Pediatr"},{"key":"1626_CR22","unstructured":"Niehus T, Wagner N, Sch\u00fctz C et\u00a0al Immunmodulierende Substanzen und Zytostatika in der p\u00e4diatrischen Rheumatologie (Kapitel\u00a016. In: Wagner N, Dannecker G, Kallinich T (Hrsg) P\u00e4diatrische Rheumatologie, 3.\u00a0Aufl. Springer, S\u00a0220\u2013221"},{"issue":"7","key":"1626_CR23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1136\/annrheumdis-2017-211968","volume":"77","author":"J Klotsche","year":"2018","unstructured":"Klotsche\u00a0J, Minden\u00a0K, Niewerth\u00a0M et\u00a0al (2018) Time spent in inactive disease before MTX withdrawal is relevant with regard to the flare risk in patients with JIA. Ann Rheum Dis 77(7):996\u20131002","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1626_CR24","first-page":"845","volume":"28","author":"CD Brooks","year":"2001","unstructured":"Brooks\u00a0CD (2001) Sulfasalazine for the management of juvenile rheumatoid arthritis. J\u00a0Rheumatol 28(4):845\u2013853","journal-title":"J Rheumatol"},{"issue":"42","key":"1626_CR25","first-page":"703","volume":"116","author":"T Niehues","year":"2019","unstructured":"Niehues\u00a0T, Ozgur\u00a0TT (2019) The efficacy and evidence-based use of biologics in children and adolescents: using monoclonal antibodies and fusion proteins as treatments. Dtsch \u00c4rztebl Int 116(42):703\u2013710","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"7","key":"1626_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/art.40466","volume":"70","author":"HI Brunner","year":"2018","unstructured":"Brunner\u00a0HI, Tzaribachev\u00a0N, Vega-Cornejo\u00a0C et\u00a0al (2018) Subcutaneous abatacept in patients with polyarticular-course juvenile idiopathic arthritis: results from a\u00a0phase\u00a0III open-label study. Arthritis Rheumatol 70(7):1144\u20131154","journal-title":"Arthritis Rheumatol"},{"key":"1626_CR27","unstructured":"Brunner HI, Ruperto N, Ramanan AV et\u00a0al (2024) Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis. Rheumatology"},{"key":"1626_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/rheumatology\/kev284","volume":"55","author":"D Hilderson","year":"2016","unstructured":"Hilderson\u00a0D, Moons\u00a0P, Van der Elst\u00a0K et\u00a0al (2016) The clinical impact of a\u00a0brief transition programme for young people with juvenile idiopathic arthritis: results of the DON\u2019T RETARD project. Rheumatology 55:133\u2013142","journal-title":"Rheumatology"},{"key":"1626_CR29","volume-title":"Gesellschaft f\u00fcr Transitionsmedizin. S3-Leitlinie Von der P\u00e4diatrie in die Erwachsenenmedizin","author":"G Ernst","year":"2021","unstructured":"Ernst\u00a0G, Pape\u00a0L et\u00a0al (2021) Gesellschaft f\u00fcr Transitionsmedizin. S3-Leitlinie Von der P\u00e4diatrie in die Erwachsenenmedizin"},{"key":"1626_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/art.39554","author":"P White","year":"2016","unstructured":"White\u00a0P, Ardoin\u00a0S (2016) Transitioning wisely: improving the connection from pediatric to adult health care. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/art.39554","journal-title":"Arthritis Rheumatol."},{"key":"1626_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00393-016-0140-0","volume":"75","author":"K Minden","year":"2016","unstructured":"Minden\u00a0K, Schalm\u00a0S (2016) Transition von der Kinder- und Jugendrheumatologie in die internistische Rheumatologie. Z\u00a0Rheumatol 75:635\u2013645","journal-title":"Z Rheumatol"},{"issue":"1","key":"1626_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.40350","volume":"70","author":"PA Nigrovic","year":"2018","unstructured":"Nigrovic\u00a0PA, Raychaudhuri\u00a0S, Thompson\u00a0SD (2018) Review: Genetics and the Classification of Arthritis in Adults and Children. Arthritis Rheumatol 70(1):7\u201317. https:\/\/doi.org\/10.1002\/art.40350 (Epub 2017 Dec 1. PMID: 29024575; PMCID: PMC5805142)","journal-title":"Arthritis Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-025-01626-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-025-01626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T11:43:39Z","timestamp":1740570219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-025-01626-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s00393-025-01626-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"15 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"N.\u00a0Br\u00fcck: A.\u00a0Finanzielle Interessen: Vortragshonorar f\u00fcr Chugai Pharma, Adboard-Teilnahme Firma Fresenius Kabi.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellte Ober\u00e4rztin P\u00e4diatrische Rheumatologie an der Klinik f\u00fcr Kinder- und Jugendmedizin, Universit\u00e4tsklinikum Carl Gustav Carus der Technischen Universit\u00e4t Dresden; Sprecherin der Kommission Leitlinien und Pharmakotherapie der Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie | Mitgliedschaften: GKJR, DGKJ, PReS. C.\u00a0Reiser: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Medizinische Fakult\u00e4t T\u00fcbingen (T\u00dcFF Programm No. 3050-0-0).\u00a0\u2013 Honorare erhalten f\u00fcr Vortr\u00e4ge\/Advisory Boards oder Reisekostenunterst\u00fctzung von MSD, Novartis, Pfizer, sobi, Galapagos, UCB.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellte Kinder\u00e4rztin, Universit\u00e4tskinderklinik T\u00fcbingen; Angestellte Kinder\u00e4rztin, Landeskrankenhaus Bregenz | Mitgliedschaften: GKJR, \u00d6GR, DGKJ, \u00d6GKJ, PReS, PRINTO. P.T.\u00a0Oommen: A.\u00a0Finanzielle Interessen: Vortragshonorare oder Kostenerstattung als passiv Teilnehmende: Novartis: Derma trifft Rheuma (Fachvortrag).\u00a0\u2013 B. Nichtfinanzielle Interessen: Bereichsleiter und Oberarzt am Uniklinikum D\u00fcsseldorf  | Mitgliedschaften folgender Fachgesellschaften: DGKJ, GKJR, GPOH, DGPPS. T.\u00a0Welzel: A.\u00a0Finanzielle Interessen: Vortr\u00e4ge ohne pers\u00f6nliche Honorare f\u00fcr Novartis.\u00a0\u2013 B. Nichtfinanzielle Interessen: Angestellte Ober\u00e4rztin P\u00e4diatrische Rheumatologie, Universit\u00e4ts-Kinderspital beider Basel (UKBB), Basel, Schweiz; Angestellte wissenschaftliche Ober\u00e4rztin P\u00e4diatrisches Forschungszentrum, Universit\u00e4ts-Kinderspital beider Basel (UKBB), Basel, Schweiz; Sprecherin der Kommission Leitlinien und Pharmakotherapie der Gesellschaft f\u00fcr Kinder- und Jugendrheumatologie | Mitgliedschaften: VSAO, PRS, GKJR, ISSAID, PReS.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}